Aliases & Classifications for Covid-19

MalaCards integrated aliases for Covid-19:

Name: Covid-19 12 15
Wuhan Seafood Market Pneumonia Virus Infection 12
Wuhan Coronavirus Infection 12
2019 Novel Coronavirus 12
2019-Ncov Infection 12

Classifications:



External Ids:

Disease Ontology 12 DOID:0080600

Summaries for Covid-19

Disease Ontology : 12 A Coronavirus infection that is characterized by fever, cough and shortness of breath and that has material basis in SARS-CoV-2.

MalaCards based summary : Covid-19, also known as wuhan seafood market pneumonia virus infection, is related to middle east respiratory syndrome and pneumonia. An important gene associated with Covid-19 is ACE2 (Angiotensin I Converting Enzyme 2), and among its related pathways/superpathways are Hematopoietic cell lineage and Agents Acting on the Renin-Angiotensin System Pathway, Pharmacodynamics. The drugs Eprosartan and Nicardipine have been mentioned in the context of this disorder. Affiliated tissues include testes, lung and liver.

Related Diseases for Covid-19

Diseases related to Covid-19 via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 951, show less)
# Related Disease Score Top Affiliating Genes
1 middle east respiratory syndrome 31.0 TMPRSS2 FURIN DPP4 CTSL ACE2
2 pneumonia 30.4 IL6 CRP CD8A ACE
3 viral pneumonia 30.3 IL6 CRP CD8A ACE2
4 pericardial effusion 30.1 IL6 CRP ACE
5 pericarditis 29.9 IL6 CRP ACE
6 purpura 29.9 IL6 CRP ACE
7 exanthem 29.8 IL6 CRP CD8A ACE
8 chickenpox 29.8 IL6 CRP CD8A
9 bacterial pneumonia 29.8 IL6 CRP CD8A
10 sleep apnea 29.8 IL6 CRP ACE
11 severe acute respiratory syndrome 29.7 TMPRSS2 IL6 FURIN CTSL CRP AGTR2
12 aspiration pneumonia 29.7 IL6 CRP ACE
13 sleep disorder 29.6 IL6 CRP ACE
14 pharyngitis 29.6 IL6 CRP CD8A
15 neuroretinitis 29.5 CRP ACE
16 hypersensitivity vasculitis 29.5 IL6 CRP ACE
17 viral exanthem 29.4 CRP CD8A
18 pulmonary disease, chronic obstructive 29.4 IL6 CRP CD8A ACE
19 bronchopneumonia 29.4 IL6 CRP CD8A
20 intermediate coronary syndrome 29.4 IL6 DPP4 CRP ACE
21 acute cystitis 29.4 IL6 DPP4 CRP ACE
22 juvenile rheumatoid arthritis 29.4 IL6 IL2RA CRP
23 acute interstitial pneumonia 29.3 CRP CD8A
24 thyroid gland disease 29.3 IL6 CRP ACE
25 orchitis 29.3 IL6 CRP CD8A
26 pneumocystosis 29.3 IL6 CRP CD8A
27 iridocyclitis 29.2 IL6 CRP ACE
28 uremia 29.2 IL6 CRP ACE
29 meningoencephalitis 29.2 IL6 CRP CD8A
30 celiac disease 1 29.2 IL6 IL2RA DPP4 CRP CD8A
31 retinal artery occlusion 29.2 IL6 CRP ACE
32 stroke, ischemic 29.2 IL6 CRP AGTR2 ACE2 ACE
33 carotid artery disease 29.2 IL6 CRP ACE
34 angioedema 29.1 DPP4 AGTR2 ACE
35 pulmonary tuberculosis 29.1 IL6 IL2RA CRP
36 syphilis 29.1 IL6 CRP CD8A ACE
37 prediabetes syndrome 29.0 IL6 DPP4 CRP ACE
38 aortic aneurysm, familial abdominal, 1 29.0 IL6 CTSL CRP ACE
39 systemic scleroderma 29.0 IL6 CRP CD8A ACE
40 intestinal obstruction 29.0 IL6 CRP CD8A
41 cellulitis 29.0 IL6 CRP CD8A
42 sarcoidosis 1 29.0 IL2RA CRP CD8A ACE
43 kidney disease 28.8 IL6 DPP4 CRP AGTR2 ACE2 ACE
44 myocardial infarction 28.7 IL6 DPP4 CRP AGTR2 ACE2 ACE
45 coronavirus infectious disease 28.6 TMPRSS2 IL6 FURIN DPP4 CTSL CRP
46 pancytopenia 28.3 IL6 IL2RA CRP CD8A ACE
47 hydronephrosis 28.1 IL6 CRP AGTR2
48 pulmonary fibrosis, idiopathic 28.0 IL6 CRP CD8A AGTR2 ACE
49 hypertension, essential 26.6 IL6 FURIN DPP4 CRP CD8A AGTR2
50 nosophobia 11.3
51 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.9
52 disease of mental health 10.7
53 respiratory failure 10.7
54 lymphopenia 10.6
55 pulmonary embolism 10.5
56 cytokine deficiency 10.5
57 myocarditis 10.5
58 inflammatory bowel disease 10.5
59 diarrhea 10.4
60 anxiety 10.4
61 thrombosis 10.4
62 lung disease 10.4
63 pustulosis of palm and sole 10.4
64 psoriasis 10.4
65 ischemia 10.4
66 heart disease 10.4
67 influenza 10.4
68 liver disease 10.3
69 diabetes mellitus 10.3
70 toxic shock syndrome 10.3
71 conjunctivitis 10.3
72 cardiac arrest 10.3
73 storm syndrome 10.3
74 thrombocytopenia 10.3
75 cerebrovascular disease 10.3
76 subacute delirium 10.3
77 congestive heart failure 10.3
78 multiple sclerosis 10.3
79 cold agglutinin disease 10.3 IL6 CRP
80 kawasaki disease 10.2
81 disseminated intravascular coagulation 10.2
82 neutropenia 10.2
83 guillain-barre syndrome 10.2
84 refractory hairy cell leukemia 10.2 IL2RA FURIN
85 prosthetic joint infection 10.2 IL6 CRP
86 cryopyrin-associated periodic syndrome 10.2 IL6 CRP
87 chronic kidney disease 10.2
88 perniosis 10.2
89 mediastinum teratoma 10.2 CRP ACE
90 body mass index quantitative trait locus 11 10.2
91 body mass index quantitative trait locus 9 10.2
92 body mass index quantitative trait locus 8 10.2
93 body mass index quantitative trait locus 4 10.2
94 body mass index quantitative trait locus 10 10.2
95 body mass index quantitative trait locus 7 10.2
96 body mass index quantitative trait locus 12 10.2
97 body mass index quantitative trait locus 14 10.2
98 body mass index quantitative trait locus 18 10.2
99 body mass index quantitative trait locus 19 10.2
100 body mass index quantitative trait locus 20 10.2
101 pulmonary edema 10.2
102 pulmonary fibrosis 10.2
103 lupus erythematosus 10.2
104 uremic pruritus 10.2 IL6 CRP
105 systemic autoimmune disease 10.2 IL6 CRP
106 autoimmune disease 10.2
107 dermatitis 10.2
108 encephalopathy 10.2
109 acute dacryoadenitis 10.2 CRP ACE
110 thrombophilia due to thrombin defect 10.2
111 common cold 10.2
112 urticaria 10.2
113 hyperglycemia 10.2
114 acute stress disorder 10.2
115 vasculitis 10.2
116 cardiac tuberculosis 10.2 CRP ACE
117 pneumothorax 10.2
118 post-traumatic stress disorder 10.2
119 lung cancer 10.2
120 dermatitis, atopic 10.2
121 malaria 10.2
122 fuchs' heterochromic uveitis 10.2 IL6 ACE
123 colorectal cancer 10.2
124 aging 10.2
125 asthma 10.2
126 rhinitis 10.2
127 posterior scleritis 10.2 CRP ACE
128 tolosa-hunt syndrome 10.2 CRP ACE
129 systemic lupus erythematosus 10.1
130 headache 10.1
131 multiple cranial nerve palsy 10.1 CRP ACE
132 myeloma, multiple 10.1
133 skin disease 10.1
134 acute myocardial infarction 10.1
135 encephalitis 10.1
136 granulomatous angiitis 10.1 CRP ACE
137 fibrosis of extraocular muscles, congenital, 1 10.1
138 hemopericardium 10.1
139 silent myocardial infarction 10.1 CRP ACE
140 hidradenitis suppurativa 10.1
141 hidradenitis 10.1
142 appendicitis 10.1
143 eating disorder 10.1
144 fatty liver disease 10.1
145 47,xyy 10.1
146 macrophage activation syndrome 10.1
147 endotheliitis 10.1
148 maturity-onset diabetes of the young, type 1 10.1 DPP4 CRP ACE
149 mental depression 10.1 IL6 DPP4 CRP
150 diabetes mellitus, ketosis-prone 10.1
151 bacterial infectious disease 10.1
152 generalized anxiety disorder 10.1
153 epilepsy 10.1
154 skin carcinoma 10.1
155 liver cirrhosis 10.1
156 bronchiectasis 10.1
157 sickle cell disease 10.1
158 oral cancer 10.1
159 cardiogenic shock 10.1
160 balanitis 10.1 DPP4 CRP
161 prostate cancer 10.1
162 ataxia and polyneuropathy, adult-onset 10.1
163 hemophagocytic lymphohistiocytosis 10.1
164 erythema multiforme 10.1
165 dementia 10.1
166 vascular disease 10.1
167 melanoma 10.1
168 pik3ca-related overgrowth syndrome 10.1
169 cholesterol embolism 10.1 CRP ACE
170 uveoparotid fever 10.0 CD8A ACE
171 optic papillitis 10.0 CRP ACE
172 pre-eclampsia 10.0
173 interstitial lung disease 10.0
174 bronchitis 10.0
175 measles 10.0
176 dysphagia 10.0
177 spinal cord injury 10.0
178 limited scleroderma 10.0 IL2RA CRP ACE
179 obsessive-compulsive disorder 10.0
180 pulmonary hypertension, primary, 1 10.0
181 scleroderma, familial progressive 10.0
182 coronary heart disease 1 10.0
183 melanoma, cutaneous malignant 10 10.0
184 plague 10.0
185 movement disease 10.0
186 48,xyyy 10.0
187 granulomatous myositis 10.0 CD8A ACE
188 bladder cancer 10.0
189 autism 10.0
190 psoriatic arthritis 10.0
191 encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 10.0
192 pulmonary hypertension 10.0
193 ulcerative colitis 10.0
194 myeloid leukemia 10.0
195 alopecia 10.0
196 hypoglycemia 10.0
197 chronic pain 10.0
198 secondary hemophagocytic lymphohistiocytosis 10.0
199 cervicitis 10.0 IL6 IL2RA CD8A
200 gingival overgrowth 10.0 IL6 CTSL ACE
201 neurofibromatosis, type ii 10.0
202 migraine with or without aura 1 10.0
203 cystic fibrosis 10.0
204 intraocular pressure quantitative trait locus 10.0
205 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.0
206 lymphoma 10.0
207 rickets 10.0
208 cholera 10.0
209 thrombocytopenia due to platelet alloimmunization 10.0
210 cholecystitis 10.0
211 psychotic disorder 10.0
212 contact dermatitis 10.0
213 acute pancreatitis 10.0
214 crohn's disease 10.0
215 neuromyelitis optica 10.0
216 depression 10.0
217 hypoxia 10.0
218 generalized atherosclerosis 10.0 IL6 CRP ACE
219 scleral disease 10.0 IL6 CRP ACE
220 background diabetic retinopathy 10.0 IL6 CRP ACE
221 autoimmune disease of endocrine system 10.0 IL6 IL2RA CD8A
222 pyelitis 9.9 IL6 CRP ACE
223 hypersensitivity reaction type iii disease 9.9 IL6 CRP ACE
224 mycoplasma pneumoniae pneumonia 9.9 IL6 CRP ACE
225 angina pectoris 9.9 IL6 CRP ACE
226 skin sarcoidosis 9.9 CD8A ACE
227 tertiary syphilis 9.9 CRP CD8A
228 acute pyelonephritis 9.9 IL6 CRP ACE
229 pyelonephritis 9.9 IL6 CRP ACE
230 hepatocellular carcinoma 9.9
231 osteoporosis 9.9
232 schizophrenia 9.9
233 prostatic hyperplasia, benign 9.9
234 allergic rhinitis 9.9
235 endometrial cancer 9.9
236 bone mineral density quantitative trait locus 8 9.9
237 bone mineral density quantitative trait locus 15 9.9
238 variola major 9.9
239 limb ischemia 9.9
240 autism spectrum disorder 9.9
241 aortic dissection 9.9
242 prostatic hypertrophy 9.9
243 adult respiratory distress syndrome 9.9
244 allergic hypersensitivity disease 9.9
245 leukemia 9.9
246 status epilepticus 9.9
247 rectum cancer 9.9
248 transient cerebral ischemia 9.9
249 glucosephosphate dehydrogenase deficiency 9.9
250 prostatic adenoma 9.9
251 antiphospholipid syndrome 9.9
252 acute kidney failure 9.9
253 mouth disease 9.9
254 myopathy 9.9
255 ebola hemorrhagic fever 9.9
256 pancreatitis 9.9
257 connective tissue disease 9.9
258 end stage renal disease 9.9
259 smallpox 9.9
260 hypereosinophilic syndrome 9.9
261 acute mountain sickness 9.9
262 endocardium disease 9.9 IL6 CRP ACE
263 pulmonary artery disease 9.9 IL6 CRP ACE
264 apnea, obstructive sleep 9.9 IL6 CRP ACE
265 systolic heart failure 9.9 IL6 CRP ACE
266 intermittent claudication 9.9 IL6 CRP ACE
267 vein disease 9.9 IL6 CRP ACE
268 parasitic helminthiasis infectious disease 9.9 IL6 CTSL CD8A
269 tracheitis 9.9 IL6 FURIN CRP
270 mineral metabolism disease 9.9 IL6 CRP ACE
271 coronary stenosis 9.9 IL6 CRP ACE
272 alzheimer disease 9.9
273 alopecia, androgenetic, 1 9.9
274 cardiac conduction defect 9.9
275 renal cell carcinoma, nonpapillary 9.9
276 ovarian cancer 9.9
277 immune deficiency disease 9.9
278 myasthenia gravis 9.9
279 pancreatic cancer 9.9
280 anemia, x-linked, with or without neutropenia and/or platelet abnormalities 9.9
281 granulomatosis with polyangiitis 9.9
282 human immunodeficiency virus type 1 9.9
283 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 9.9
284 aspergillosis 9.9
285 leptin deficiency or dysfunction 9.9
286 deficiency anemia 9.9
287 androgenic alopecia 9.9
288 atrioventricular block 9.9
289 pain agnosia 9.9
290 colitis 9.9
291 non-alcoholic fatty liver disease 9.9
292 thalassemia 9.9
293 gestational diabetes 9.9
294 uveitis 9.9
295 polyneuropathy 9.9
296 adult-onset still's disease 9.9
297 alcohol use disorder 9.9
298 substance abuse 9.9
299 acute myocarditis 9.9
300 infertility 9.9
301 gastrointestinal system disease 9.9
302 arthritis 9.9
303 herpes simplex 9.9
304 broken heart syndrome 9.9
305 acute generalized exanthematous pustulosis 9.9
306 methanol poisoning 9.9
307 thrombotic microangiopathy 9.9
308 thyroid carcinoma 9.9
309 peripheral artery disease 9.9 IL6 CRP ACE
310 hair whorl 9.9
311 lymphoma, non-hodgkin, familial 9.9
312 west nile virus 9.9
313 sialadenitis 9.9
314 conjunctival folliculosis 9.9
315 arteriosclerosis 9.9
316 endocrine system disease 9.9
317 arteriosclerosis obliterans 9.9
318 cerebritis 9.9 CRP CD8A
319 familial vesicoureteral reflux 9.9 AGTR2 ACE
320 granulomatous hepatitis 9.9 CRP CD8A
321 retinal vascular disease 9.9 IL6 CRP ACE
322 amyotrophic lateral sclerosis 1 9.8
323 atrial standstill 1 9.8
324 leukemia, chronic lymphocytic 9.8
325 myositis 9.8
326 ocular motor apraxia 9.8
327 arts syndrome 9.8
328 yemenite deaf-blind hypopigmentation syndrome 9.8
329 spastic paraplegia, intellectual disability, nystagmus, and obesity 9.8
330 gastrointestinal ulceration, recurrent, with dysfunctional platelets 9.8
331 chikungunya 9.8
332 brugada syndrome 9.8
333 atrial fibrillation 9.8
334 visual epilepsy 9.8
335 acute leukemia 9.8
336 acute chest syndrome 9.8
337 hepatitis b 9.8
338 lateral sclerosis 9.8
339 kidney cancer 9.8
340 bronchiolitis 9.8
341 myelitis 9.8
342 heart valve disease 9.8
343 eye disease 9.8
344 peritonitis 9.8
345 extrinsic allergic alveolitis 9.8
346 herpes zoster 9.8
347 seborrheic dermatitis 9.8
348 pityriasis rosea 9.8
349 seizure disorder 9.8
350 syncope 9.8
351 sezary's disease 9.8 IL2RA DPP4 CD8A
352 hantavirus hemorrhagic fever with renal syndrome 9.8 IL6 CRP CD8A
353 central nervous system vasculitis 9.8 IL6 CRP CD8A
354 primary systemic mycosis 9.8 IL6 CRP CD8A
355 streptococcus pneumonia 9.8 IL6 CRP CD8A
356 fallopian tube disease 9.8 IL6 CRP CD8A
357 plasma protein metabolism disease 9.8 IL6 CRP CD8A
358 autoimmune disease of blood 9.8 IL6 CRP CD8A
359 vaginal disease 9.8 IL6 CRP CD8A
360 autoimmune disease of exocrine system 9.8 IL6 CRP CD8A
361 short syndrome 9.8 IL6 CRP CD8A
362 middle ear disease 9.8 IL6 CRP CD8A
363 splenic disease 9.8 IL6 CRP CD8A
364 coccidiosis 9.8 IL6 CRP CD8A
365 conjunctival disease 9.8 IL6 CRP CD8A
366 paranasal sinus disease 9.8 IL6 CRP CD8A
367 rectal disease 9.8 IL6 CRP CD8A
368 chorioretinitis 9.8 IL6 CD8A ACE
369 opportunistic mycosis 9.8 IL6 CRP CD8A
370 spinal cord disease 9.8 IL6 CRP CD8A
371 fungal infectious disease 9.8 IL6 CRP CD8A
372 glucose metabolism disease 9.8 IL6 DPP4 CRP ACE
373 lymph node disease 9.8 IL6 CRP CD8A
374 nose disease 9.8 IL6 CRP CD8A
375 abcd syndrome 9.8
376 macular degeneration, age-related, 1 9.8
377 ventricular fibrillation, paroxysmal familial, 1 9.8
378 body mass index quantitative trait locus 1 9.8
379 anorexia nervosa 9.8
380 down syndrome 9.8
381 triiodothyronine receptor auxiliary protein 9.8
382 rheumatoid arthritis 9.8
383 pneumothorax, primary spontaneous 9.8
384 intussusception 9.8
385 attention deficit-hyperactivity disorder 9.8
386 esophageal cancer 9.8
387 breast cancer 9.8
388 arteries, anomalies of 9.8
389 leukemia, chronic myeloid 9.8
390 major affective disorder 8 9.8
391 major affective disorder 9 9.8
392 leukemia, acute lymphoblastic 9.8
393 cyanosis, transient neonatal 9.8
394 dengue virus 9.8
395 alacrima, achalasia, and mental retardation syndrome 9.8
396 leukemia, acute lymphoblastic 3 9.8
397 bacterial sepsis 9.8
398 metabolic acidosis 9.8
399 ectopic pregnancy 9.8
400 urolithiasis 9.8
401 mumps 9.8
402 endocarditis 9.8
403 cardiac tamponade 9.8
404 penile cancer 9.8
405 coronary thrombosis 9.8
406 dengue disease 9.8
407 quadriplegia 9.8
408 miller fisher syndrome 9.8
409 cholestasis 9.8
410 eclampsia 9.8
411 keratosis 9.8
412 viral hepatitis 9.8
413 intestinal perforation 9.8
414 hepatitis 9.8
415 gastroenteritis 9.8
416 agammaglobulinemia 9.8
417 demyelinating disease 9.8
418 bipolar disorder 9.8
419 mood disorder 9.8
420 arthropathy 9.8
421 neuromuscular disease 9.8
422 poliomyelitis 9.8
423 active peptic ulcer disease 9.8
424 hyperthyroidism 9.8
425 periodontitis 9.8
426 osteoarthritis 9.8
427 neuropathy 9.8
428 decubitus ulcer 9.8
429 pemphigus 9.8
430 meningitis 9.8
431 postpartum depression 9.8
432 alopecia areata 9.8
433 hemophilia 9.8
434 back pain 9.8
435 malignant tumor of penis 9.8
436 glucose intolerance 9.8 IL6 DPP4 CRP ACE
437 autoimmune disease of gastrointestinal tract 9.8 IL6 CRP CD8A
438 commensal bacterial infectious disease 9.8 IL6 CRP CD8A
439 acquired metabolic disease 9.8 IL6 DPP4 CRP ACE
440 neurosarcoidosis 9.8 CRP CD8A ACE
441 facial nerve disease 9.8 CRP CD8A ACE
442 facial paralysis 9.8 CRP CD8A ACE
443 temporal arteritis 9.8 IL6 CRP CD8A
444 pleural disease 9.8 IL6 CRP CD8A
445 stomach disease 9.8 IL6 CRP CD8A
446 vascular dementia 9.8 IL6 CRP ACE
447 blood coagulation disease 9.7 IL6 CRP CD8A
448 lymphoid interstitial pneumonia 9.7 IL6 CRP CD8A
449 potocki-shaffer syndrome 9.7 IL6 CRP CD8A
450 parasitic protozoa infectious disease 9.7 IL6 CRP CD8A
451 leukemia, acute myeloid 9.7
452 psoriasis 4 9.7
453 cervical cancer 9.7
454 psoriasis 6 9.7
455 hemophilia a 9.7
456 abnormal hair, joint laxity, and developmental delay 9.7
457 lymphoma, hodgkin, classic 9.7
458 anemia, autoimmune hemolytic 9.7
459 tetralogy of fallot 9.7
460 pemphigus vulgaris, familial 9.7
461 otitis media 9.7
462 hypertriglyceridemia, familial 9.7
463 hypercholesterolemia, familial, 1 9.7
464 coronary artery dissection, spontaneous 9.7
465 progressive familial heart block, type ia 9.7
466 bulimia nervosa 9.7
467 phobia, specific 9.7
468 myopathy, myosin storage, autosomal dominant 9.7
469 aplastic anemia 9.7
470 lung cancer susceptibility 3 9.7
471 microvascular complications of diabetes 5 9.7
472 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 9.7
473 neurodegeneration with brain iron accumulation 6 9.7
474 hyperlipoproteinemia, type iii 9.7
475 joint laxity, short stature, and myopia 9.7
476 juvenile arthritis 9.7
477 lipoprotein quantitative trait locus 9.7
478 peripheral vascular disease 9.7
479 west syndrome 9.7
480 swine influenza 9.7
481 epidemic typhus 9.7
482 uterine corpus endometrial carcinoma 9.7
483 endocervical adenocarcinoma 9.7
484 infective endocarditis 9.7
485 drug allergy 9.7
486 catecholaminergic polymorphic ventricular tachycardia 9.7
487 physical disorder 9.7
488 sensorineural hearing loss 9.7
489 portal hypertension 9.7
490 methemoglobinemia 9.7
491 kuhnt-junius degeneration 9.7
492 hand, foot and mouth disease 9.7
493 sarcoma 9.7
494 anogenital venereal wart 9.7
495 rabies 9.7
496 chlamydia 9.7
497 myopia 9.7
498 hypertrophic cardiomyopathy 9.7
499 optic neuritis 9.7
500 inflammatory spondylopathy 9.7
501 common variable immunodeficiency 9.7
502 carotid stenosis 9.7
503 hyperparathyroidism 9.7
504 familial hypercholesterolemia 9.7
505 squamous cell papilloma 9.7
506 neuroleptic malignant syndrome 9.7
507 hypothyroidism 9.7
508 neuroendocrine tumor 9.7
509 neuritis 9.7
510 impotence 9.7
511 hepatitis c 9.7
512 rectum adenocarcinoma 9.7
513 enthesopathy 9.7
514 constipation 9.7
515 thrombocytosis 9.7
516 colon adenocarcinoma 9.7
517 relapsing-remitting multiple sclerosis 9.7
518 papilloma 9.7
519 irritant dermatitis 9.7
520 long qt syndrome 9.7
521 bruxism 9.7
522 hemoglobinopathy 9.7
523 endometriosis 9.7
524 immune system disease 9.7
525 glomerulonephritis 9.7
526 food allergy 9.7
527 glioblastoma multiforme 9.7
528 lipid metabolism disorder 9.7
529 pseudomyxoma peritonei 9.7
530 pancreatic adenocarcinoma 9.7
531 intracranial thrombosis 9.7
532 spindle cell sarcoma 9.7
533 avian influenza 9.7
534 hypokalemia 9.7
535 nutritional deficiency disease 9.7
536 aortic disease 9.7
537 hemolytic anemia 9.7
538 panic disorder 9.7
539 acute disseminated encephalomyelitis 9.7
540 spondylitis 9.7
541 b-cell lymphoma 9.7
542 muscular atrophy 9.7
543 placenta disease 9.7
544 scabies 9.7
545 cataract 9.7
546 bullous pemphigoid 9.7
547 acute cor pulmonale 9.7
548 rubella 9.7
549 actinic keratosis 9.7
550 skin melanoma 9.7
551 lichen planus 9.7
552 keratoconjunctivitis 9.7
553 hypopituitarism 9.7
554 lassa fever 9.7
555 catastrophic antiphospholipid syndrome 9.7
556 cough headache 9.7
557 granulocytopenia 9.7
558 transverse myelitis 9.7
559 spasticity 9.7
560 swallowing disorders 9.7
561 tremor 9.7
562 acute transverse myelitis 9.7
563 overgrowth syndrome 9.7
564 blood platelet disease 9.7 IL6 CRP CD8A
565 autoimmune disease of musculoskeletal system 9.7 IL6 CRP CD8A
566 ectodermal dysplasia 10b, hypohidrotic/hair/tooth type, autosomal recessive 9.7 IL6 FURIN CD8A
567 bronchial disease 9.6 IL6 CRP CD8A
568 primary bacterial infectious disease 9.6 IL6 CRP CD8A
569 frontotemporal dementia 9.5
570 schizophrenia 3 9.5
571 suppression of tumorigenicity 12 9.5
572 psoriasis 3 9.5
573 autoimmune lymphoproliferative syndrome 9.5
574 branchiootic syndrome 1 9.5
575 schizophrenia 2 9.5
576 sickle cell anemia 9.5
577 psoriasis 5 9.5
578 progressive familial heart block, type ib 9.5
579 myopathy, distal, with anterior tibial onset 9.5
580 properdin deficiency, x-linked 9.5
581 mental retardation with optic atrophy, deafness, and seizures 9.5
582 fabry disease 9.5
583 agammaglobulinemia, x-linked 9.5
584 muscular dystrophy, becker type 9.5
585 squamous cell carcinoma, head and neck 9.5
586 graves disease 1 9.5
587 thymoma, familial 9.5
588 sjogren syndrome 9.5
589 senior-loken syndrome 1 9.5
590 pyruvate kinase deficiency of red cells 9.5
591 phenylketonuria 9.5
592 obesity-hypoventilation syndrome 9.5
593 leprosy 3 9.5
594 hypogonadism, male 9.5
595 hydatidiform mole, recurrent, 1 9.5
596 cystinuria 9.5
597 lipoid congenital adrenal hyperplasia 9.5
598 vasculitis, lymphocytic, nodular 9.5
599 varicose veins 9.5
600 trigeminal neuralgia 9.5
601 small cell cancer of the lung 9.5
602 keratosis, seborrheic 9.5
603 schistosoma mansoni infection, susceptibility/ 9.5
604 retinoblastoma 9.5
605 retinal detachment 9.5
606 dowling-degos disease 1 9.5
607 proline-negative auxotroph of hamster, complementation of 9.5
608 polykaryocytosis inducer 9.5
609 pityriasis rubra pilaris 9.5
610 oculopharyngeal muscular dystrophy 9.5
611 ocular cicatricial pemphigoid 9.5
612 melanoma, uveal 9.5
613 thyroid carcinoma, familial medullary 9.5
614 marfan syndrome 9.5
615 lentigines 9.5
616 keratitis, hereditary 9.5
617 kaposi sarcoma 9.5
618 gilles de la tourette syndrome 9.5
619 neuromyotonia and axonal neuropathy, autosomal recessive 9.5
620 eosinophilopenia 9.5
621 cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 9.5
622 cornelia de lange syndrome 1 9.5
623 cardiac arrhythmia 9.5
624 spondyloarthropathy 1 9.5
625 alcohol dependence 9.5
626 abducens palsy 9.5
627 nasopharyngeal carcinoma 9.5
628 spastic paraplegia, ataxia, and mental retardation 9.5
629 hypertensive nephropathy 9.5
630 myocardial infarction 2 9.5
631 asthma-related traits 4 9.5
632 psoriasis 10 9.5
633 microvascular complications of diabetes 3 9.5
634 microvascular complications of diabetes 4 9.5
635 microvascular complications of diabetes 6 9.5
636 microvascular complications of diabetes 7 9.5
637 hypotrichosis and recurrent skin vesicles 9.5
638 fatty liver disease, nonalcoholic 1 9.5
639 alpha-1-antitrypsin deficiency 9.5
640 beta-thalassemia 9.5
641 myelodysplastic syndrome 9.5
642 graft-versus-host disease 9.5
643 cerebellar ataxia, neuropathy, and vestibular areflexia syndrome 9.5
644 melioidosis 9.5
645 cholangiocarcinoma 9.5
646 carbonic anhydrase va deficiency, hyperammonemia due to 9.5
647 global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies 9.5
648 chlamydia pneumonia 9.5
649 livedoid vasculitis 9.5
650 invasive aspergillosis 9.5
651 autoimmune polyendocrine syndrome type 1 9.5
652 cutaneous lupus erythematosus 9.5
653 lambert-eaton myasthenic syndrome 9.5
654 small cell carcinoma 9.5
655 diffuse large b-cell lymphoma 9.5
656 mantle cell lymphoma 9.5
657 secondary progressive multiple sclerosis 9.5
658 primary progressive multiple sclerosis 9.5
659 short qt syndrome 9.5
660 rheumatic heart disease 9.5
661 withdrawal disorder 9.5
662 immunoglobulin alpha deficiency 9.5
663 aphasia 9.5
664 estrogen-receptor positive breast cancer 9.5
665 brain glioma 9.5
666 alexithymia 9.5
667 ischemic colitis 9.5
668 inguinal hernia 9.5
669 pollen allergy 9.5
670 spinal disease 9.5
671 post-cardiac arrest syndrome 9.5
672 chromosomal disease 9.5
673 myoglobinuria 9.5
674 childhood acute lymphocytic leukemia 9.5
675 meningococcal meningitis 9.5
676 mucositis 9.5
677 adenoid cystic carcinoma 9.5
678 igg4-related disease 9.5
679 non-alcoholic steatohepatitis 9.5
680 multicentric castleman disease 9.5
681 castleman disease 9.5
682 distal muscular dystrophy with anterior tibial onset 9.5
683 corneal disease 9.5
684 cerebral artery occlusion 9.5
685 venous insufficiency 9.5
686 xerophthalmia 9.5
687 osteonecrosis 9.5
688 left bundle branch hemiblock 9.5
689 parotitis 9.5
690 tonsillitis 9.5
691 interstitial nephritis 9.5
692 thrombotic thrombocytopenic purpura 9.5
693 bubonic plague 9.5
694 salivary gland disease 9.5
695 hydrocephalus 9.5
696 gastrojejunal ulcer 9.5
697 cholesteatoma of middle ear 9.5
698 meconium aspiration syndrome 9.5
699 pulpitis 9.5
700 miliaria rubra 9.5
701 pertussis 9.5
702 acute conjunctivitis 9.5
703 hypoparathyroidism 9.5
704 esophageal varix 9.5
705 primary hyperparathyroidism 9.5
706 acute hemorrhagic conjunctivitis 9.5
707 orbital cellulitis 9.5
708 solar retinopathy 9.5
709 erysipelas 9.5
710 epidural abscess 9.5
711 mitral valve insufficiency 9.5
712 infant gynecomastia 9.5
713 polycystic ovary syndrome 9.5
714 cornelia de lange syndrome 9.5
715 choledocholithiasis 9.5
716 cortical blindness 9.5
717 nephrotic syndrome 9.5
718 conn's syndrome 9.5
719 hemosiderosis 9.5
720 goiter 9.5
721 crimean-congo hemorrhagic fever 9.5
722 spinal muscular atrophy 9.5
723 dysentery 9.5
724 vulva cancer 9.5
725 bell's palsy 9.5
726 von willebrand's disease 9.5
727 hepatitis a 9.5
728 acute kidney tubular necrosis 9.5
729 acoustic neuroma 9.5
730 locked-in syndrome 9.5
731 gynecomastia 9.5
732 hereditary hemorrhagic telangiectasia 9.5
733 telangiectasis 9.5
734 keratoconjunctivitis sicca 9.5
735 dilated cardiomyopathy 9.5
736 branch retinal artery occlusion 9.5
737 central retinal artery occlusion 9.5
738 right bundle branch block 9.5
739 porphyria 9.5
740 megaloblastic anemia 9.5
741 pulmonary sarcoidosis 9.5
742 biliary atresia 9.5
743 patent foramen ovale 9.5
744 photokeratitis 9.5
745 miliaria 9.5
746 amenorrhea 9.5
747 schistosomiasis 9.5
748 autoimmune polyendocrine syndrome 9.5
749 anus cancer 9.5
750 blue toe syndrome 9.5
751 capillary leak syndrome 9.5
752 geographic tongue 9.5
753 hereditary angioedema 9.5
754 candidiasis 9.5
755 panniculitis 9.5
756 lymphadenitis 9.5
757 ventricular septal defect 9.5
758 cystitis 9.5
759 heart septal defect 9.5
760 squamous cell carcinoma 9.5
761 cheilitis 9.5
762 hypogonadism 9.5
763 telogen effluvium 9.5
764 benign giant cell tumor 9.5
765 neuroma 9.5
766 hyperinsulinism 9.5
767 autoimmune hepatitis 9.5
768 ocular cancer 9.5
769 factor xiii deficiency 9.5
770 thrombophilia 9.5
771 sensory peripheral neuropathy 9.5
772 hematologic cancer 9.5
773 benign mesothelioma 9.5
774 transitional cell carcinoma 9.5
775 acrodermatitis 9.5
776 tic disorder 9.5
777 acalculous cholecystitis 9.5
778 endometrial adenocarcinoma 9.5
779 laryngeal squamous cell carcinoma 9.5
780 adenocarcinoma 9.5
781 testicular cancer 9.5
782 allergic contact dermatitis 9.5
783 churg-strauss syndrome 9.5
784 gingivitis 9.5
785 thoracic outlet syndrome 9.5
786 papillary carcinoma 9.5
787 facial dermatosis 9.5
788 lysosomal storage disease 9.5
789 central nervous system lymphoma 9.5
790 thymoma 9.5
791 vaccinia 9.5
792 inappropriate adh syndrome 9.5
793 carotid artery thrombosis 9.5
794 mastocytosis 9.5
795 gestational trophoblastic neoplasm 9.5
796 retinitis 9.5
797 aortic aneurysm 9.5
798 lactic acidosis 9.5
799 cervical squamous cell carcinoma 9.5
800 pleural empyema 9.5
801 cranial nerve palsy 9.5
802 pituitary adenoma 9.5
803 skull base cancer 9.5
804 lynch syndrome 9.5
805 restrictive cardiomyopathy 9.5
806 thyroid gland medullary carcinoma 9.5
807 tricuspid valve insufficiency 9.5
808 carcinosarcoma 9.5
809 polyradiculoneuropathy 9.5
810 seminoma 9.5
811 nominal aphasia 9.5
812 familial retinoblastoma 9.5
813 endophthalmitis 9.5
814 brain edema 9.5
815 proliferative glomerulonephritis 9.5
816 angiokeratoma 9.5
817 intrahepatic cholangiocarcinoma 9.5
818 adenocarcinoma in situ 9.5
819 adjustment disorder 9.5
820 thoracic cancer 9.5
821 urinary tract obstruction 9.5
822 demyelinating polyneuropathy 9.5
823 acute necrotizing encephalitis 9.5
824 von economo's disease 9.5
825 schizoaffective disorder 9.5
826 retinal disease 9.5
827 oral submucous fibrosis 9.5
828 uterine carcinosarcoma 9.5
829 fibromyalgia 9.5
830 acquired immunodeficiency syndrome 9.5
831 adenoma 9.5
832 skin tag 9.5
833 inverted follicular keratosis 9.5
834 subacute thyroiditis 9.5
835 thyroiditis 9.5
836 monoclonal gammopathy of uncertain significance 9.5
837 lymphatic system disease 9.5
838 peptic ulcer disease 9.5
839 peptic ulcer perforation 9.5
840 childhood leukemia 9.5
841 carotid artery occlusion 9.5
842 bullous skin disease 9.5
843 impetigo 9.5
844 chronic fatigue syndrome 9.5
845 oropharynx cancer 9.5
846 nervous system disease 9.5
847 rosacea 9.5
848 evans' syndrome 9.5
849 narcolepsy 9.5
850 amyloidosis 9.5
851 cleft lip 9.5
852 diabetes insipidus 9.5
853 allergic asthma 9.5
854 intracranial hypertension 9.5
855 otitis externa 9.5
856 bacterial meningitis 9.5
857 plasma cell leukemia 9.5
858 smoldering myeloma 9.5
859 venezuelan equine encephalitis 9.5
860 fasciitis 9.5
861 placental abruption 9.5
862 yellow fever 9.5
863 upper respiratory tract disease 9.5
864 muscular dystrophy 9.5
865 hypoplastic left heart syndrome 9.5
866 substance dependence 9.5
867 muscular dystrophy, duchenne and becker type 9.5
868 myotonic dystrophy 9.5
869 bap1 tumor predisposition syndrome 9.5
870 multiple epiphyseal dysplasia, recessive 9.5
871 acute graft versus host disease 9.5
872 al amyloidosis 9.5
873 aquagenic syringeal acrokeratoderma 9.5
874 bk-virus nephropathy 9.5
875 bronchopulmonary dysplasia 9.5
876 candida glabrata 9.5
877 chromosomal triplication 9.5
878 chronic hiccups 9.5
879 drug reaction with eosinophilia and systemic symptoms 9.5
880 fournier gangrene 9.5
881 frontal fibrosing alopecia 9.5
882 haemophilus influenzae 9.5
883 hansen's disease 9.5
884 heparin-induced thrombocytopenia 9.5
885 homologous wasting disease 9.5
886 infectious myocarditis 9.5
887 klebsiella infection 9.5
888 mast cell activation syndrome 9.5
889 mounier-kuhn syndrome 9.5
890 myalgic encephalomyelitis/chronic fatigue syndrome 9.5
891 neonatal stroke 9.5
892 ovarian epithelial cancer 9.5
893 periodontal ehlers-danlos syndrome 9.5
894 primary central nervous system lymphoma 9.5
895 radiation induced cancer 9.5
896 reversible cerebral vasoconstriction syndrome 9.5
897 splenomegaly 9.5
898 stevens-johnson syndrome/toxic epidermal necrolysis 9.5
899 sudden sensorineural hearing loss 9.5
900 systemic onset juvenile idiopathic arthritis 9.5
901 raynaud phenomenon 9.5
902 aneurysm 9.5
903 autonomic dysfunction 9.5
904 brain injury 9.5
905 cytomegalovirus infection 9.5
906 dysautonomia 9.5
907 hypersomnia 9.5
908 myoclonus 9.5
909 occipital neuralgia 9.5
910 paresthesia 9.5
911 pituitary tumors 9.5
912 traumatic brain injury 9.5
913 cleft lip/palate 9.5
914 differentiated thyroid carcinoma 9.5
915 inflammatory myopathy with abundant macrophages 9.5
916 drug-induced vasculitis 9.5
917 pulmonary arterial hypertension associated with congenital heart disease 9.5
918 viral myositis 9.5
919 primary cutaneous lymphoma 9.5
920 rare hereditary hemochromatosis 9.5
921 avascular necrosis 9.5
922 plastic bronchitis 9.5
923 moyamoya angiopathy 9.5
924 adult acute respiratory distress syndrome 9.5
925 parenteral nutrition-associated cholestasis 9.5
926 car t cell therapy-associated cytokine release syndrome 9.5
927 serotonin syndrome 9.5
928 acute liver failure 9.5
929 acrokeratoderma 9.5
930 pediatric systemic lupus erythematosus 9.5
931 primary mediastinal large b-cell lymphoma 9.5
932 acute motor and sensory axonal neuropathy 9.5
933 undetermined colitis 9.5
934 primary adrenal insufficiency 9.5
935 posterior urethral valves 9.5 IL6 AGTR2 ACE2 ACE
936 vesicoureteral reflux 1 9.5 CRP AGTR2 ACE
937 iritis 9.5 IL6 CRP CD8A ACE
938 pericardium disease 9.5 IL6 CRP CD8A ACE
939 panuveitis 9.5 IL6 CRP CD8A ACE
940 hypersensitivity reaction type iv disease 9.5 IL6 CRP CD8A ACE
941 extrinsic cardiomyopathy 9.5 IL6 CRP CD8A ACE
942 renal hypertension 9.5 CRP AGTR2 ACE2 ACE
943 uveal disease 9.5 IL6 CRP CD8A ACE
944 integumentary system disease 9.5 IL6 CRP CD8A ACE
945 optic nerve disease 9.5 IL6 CRP CD8A ACE
946 leukocyte disease 9.4 IL6 CRP CD8A
947 chronic mucocutaneous candidiasis 9.4 IL6 IL2RA CD8A
948 peripheral nervous system disease 9.3 IL6 DPP4 CRP CD8A ACE
949 behcet syndrome 9.3 IL6 IL2RA CRP CD8A ACE
950 diabetes mellitus, type i 9.2 IL6 IL2RA DPP4 CRP CD8A ACE
951 cardiovascular system disease 9.2 IL6 CRP AGTR2 ACE2 ACE

Graphical network of the top 20 diseases related to Covid-19:



Diseases related to Covid-19

Symptoms & Phenotypes for Covid-19

Drugs & Therapeutics for Covid-19

Drugs for Covid-19 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 700, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Eprosartan Approved Phase 4 133040-01-4 5281037
2
Nicardipine Approved, Investigational Phase 4 55985-32-5 4474
3
Perindopril Approved Phase 4 107133-36-8, 82834-16-0 107807
4
Trandolapril Approved Phase 4 87679-37-6 5484727
5
Hydrochlorothiazide Approved, Vet_approved Phase 4 58-93-5 3639
6
Lisinopril Approved, Investigational Phase 4 76547-98-3, 83915-83-7 5362119
7
Irbesartan Approved, Investigational Phase 4 138402-11-6 3749
8
Valsartan Approved, Investigational Phase 4 137862-53-4 60846
9
Felodipine Approved, Investigational Phase 4 72509-76-3 3333
10
Fosinopril Approved Phase 4 98048-97-6 55891
11
Olmesartan Approved, Investigational Phase 4 144689-24-7, 144689-63-4 158781 130881
12
Nimodipine Approved, Investigational Phase 4 66085-59-4 4497
13
Nifedipine Approved Phase 4 21829-25-4 4485
14
Metolazone Approved Phase 4 17560-51-9 4170
15
Chlorothiazide Approved, Vet_approved Phase 4 58-94-6 2720
16
Amlodipine Approved Phase 4 88150-42-9 2162
17
Verapamil Approved Phase 4 52-53-9 2520
18
Chlorthalidone Approved Phase 4 77-36-1 2732
19
Indapamide Approved Phase 4 26807-65-8 3702
20
Candesartan cilexetil Approved Phase 4 145040-37-5 2540
21
Bendroflumethiazide Approved Phase 4 73-48-3 2315
22
Quinapril Approved, Investigational Phase 4 85441-61-8 54892
23
Benazepril Approved, Investigational Phase 4 86541-75-5 5362124
24
Nitrendipine Approved, Investigational Phase 4 39562-70-4 4507
25
Clarithromycin Approved Phase 4 81103-11-9 84029
26
Oseltamivir Approved Phase 4 204255-11-8, 196618-13-0 65028
27
Bromhexine Approved Phase 4 3572-43-8
28
Ceftriaxone Approved Phase 4 73384-59-5 5361919 5479530
29
Hydrocortisone Approved, Vet_approved Phase 4 50-23-7 5754
30
Hydrocortisone acetate Approved, Vet_approved Phase 4 50-03-3
31
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4 1177-87-3
32
Dexamethasone Approved, Investigational, Vet_approved Phase 4 50-02-2 5743
33
Ravulizumab Approved, Investigational Phase 4 1803171-55-2
34
Coal tar Approved Phase 4 8007-45-2
35
Ibuprofen Approved Phase 4 15687-27-1 3672
36
Clavulanate Approved, Vet_approved Phase 4 58001-44-8 5280980
37
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613
38
Nadroparin Approved, Investigational Phase 4
39
Protein C Approved Phase 4
40
Tazobactam Approved Phase 4 89786-04-9 123630